SCHEMBL10070045

SCHEMBL10070045

C=C(C)C(=O)Nc1ccc(/N=N/c2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.54
KMT2A Q03164 7/20 0.53
MEN1 O00255 6/20 0.53
NPC1 O15118 4/20 0.51
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 1/20 0.51
MAPK1 P28482 1/20 0.51
TGM2 P21980 1/20 0.50
GAA P10253 1/20 0.49
RXFP1 Q9HBX9 1/20 0.48
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP3A4 P08684 1/20 0.47
HPGD P15428 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
NOS1 P29475 1/20 0.46
RAB9A P51151 3/20 0.46
PKM P14618 1/20 0.46
PAX8 Q06710 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9551055 1.00 POLB (0.54) POLBKMT2AMEN1NPC1MAPT
SCHEMBL26092410 1.00 POLB (0.54) POLBKMT2AMEN1NPC1MAPT
SCHEMBL5005472 0.91 KMT2A (0.62) POLBKMT2AMEN1NPC1MAPT
SCHEMBL268927 0.86 RXFP1 (0.61) POLBKMT2AMEN1NPC1MAPT
SCHEMBL268926 0.86 RXFP1 (0.61) POLBKMT2AMEN1NPC1MAPT
SCHEMBL13219021 0.85 KMT2A (0.68) POLBKMT2AMEN1NPC1MAPT
SCHEMBL9193033 0.83 TGM2 (0.54) POLBKMT2AMEN1NPC1MAPT
SCHEMBL9193038 0.83 TGM2 (0.54) POLBKMT2AMEN1NPC1MAPT
SCHEMBL4126180 0.80 MAPT (0.70) POLBKMT2AMEN1NPC1MAPT
SCHEMBL10491540 0.80 MAPT (0.70) POLBKMT2AMEN1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10435566-B2 Particles for electrophoretic displays MERCK PATENT GMBH (DE) 2019-10-08 US disclosed
US-20180037744-A1 PARTICLES FOR ELECTROPHORETIC DISPLAYS E INK CORPORATION 2018-02-08 US disclosed
WO-2016096091-A1 PARTICLES FOR ELECTROPHORETIC DISPLAYS MERCK PATENT GMBH (DE) 2016-06-23 WO disclosed
US-9115464-B2 Particles for electrophoretic displays MERCK PATENT GMBH (DE) 2015-08-25 US disclosed
US-8743451-B2 Coloured particles for electrophoretic displays MERCK PATENT GMBH (DE) 2014-06-03 US disclosed
US-20120041165-A1 PARTICLES FOR ELECTROPHORETIC DISPLAYS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2012-02-16 US disclosed
US-20110306742-A1 PARTICLES FOR ELECTROPHORETIC DISPLAYS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-12-15 US disclosed
US-20110297888-A1 COLOURED PARTICLES FOR ELECTROPHORETIC DISPLAYS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-12-08 US disclosed
WO-2010089057-A2 PARTICLES FOR ELECTROPHORETIC DISPLAYS MERCK PATENT GMBH (DE) 2010-08-12 WO disclosed
WO-2010089060-A2 PARTICLES FOR ELECTROPHORETIC DISPLAYS MERCK PATENT GMBH (DE) 2010-08-12 WO disclosed
WO-2010089059-A1 COLOURED PARTICLES FOR ELECTROPHORETIC DISPLAYS MERCK PATENT GMBH (DE) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037744-A1 PARTICLES FOR ELECTROPHORETIC DISPLAYS RAB5IF, GYPA, SELP POLB 1024/4885KMT2A 4104/4885MEN1 3915/4885
US-10435566-B2 Particles for electrophoretic displays RAB5IF, SELP, SELE POLB 1448/4885KMT2A 4291/4885MEN1 3924/4885
US-20110306742-A1 PARTICLES FOR ELECTROPHORETIC DISPLAYS RAB5IF, IK, SELP POLB 1248/4885KMT2A 4136/4885MEN1 4319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.